Challenge the Buyout: Ademi & O’Reilly, LLP Investigates Whether JPS Industries, Inc.  has Obtained a Fair Price in its Sale to Handy & Harman

20:00 EDT 1 Jun 2015 | Globe Newswire

MILWAUKEE, Wis., June 01, 2015 (GLOBE NEWSWIRE) -- We are investigating the Board of Directors of JPS for possible breaches of fiduciary duty and other violations of state law in connection with the sale of JPS to HnH.

Click here to learn how to join the action: or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

JPS’s long-term financial outlook is positive and yet shareholders will receive only $11 per share.  HnH is well aware of JPS’s’ improving financial metrics and is purchasing JPS at a substantial discount.   The merger agreement unreasonably limits prospective bids by (i) prohibiting solicitation of any further bids, and (ii) imposing a termination penalty should JPS receive and accept a superior bid.  JPS’s insiders and their affiliates own significant stock, and will receive millions of dollars as part of change of control arrangements.  These insiders can unduly influence a sale of JPS not necessarily in the best interests of non-insider shareholders.  In light of these facts, our investigation centers on the conduct of JPS’s Board of Directors, who have unanimously approved the transaction, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for JPS given its current financial condition and prospects. 

If you own shares of JPS and wish to obtain additional information, please contact Guri Ademi either at or toll-free: 866-264-3995,                                 

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country.  For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.


Ademi & O’Reilly, LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001

More From BioPortfolio on "Challenge the Buyout: Ademi & O’Reilly, LLP Investigates Whether JPS Industries, Inc.  has Obtained a Fair Price in its Sale to Handy & Harman"

Quick Search


Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...